LncRNA CRNDE attenuates chemoresistance in gastric cancer via SRSF6-regulated alternative splicing of PICALM.
De novo and acquired resistance, which are mainly mediated by genetic alterations, are barriers to effective routine chemotherapy. However, the mechanisms underlying gastric cancer (GC) resistance to chemotherapy are still unclear. We showed that the long noncoding RNA CRNDE was related to the chemosensitivity of GC in clinical samples and ... a PDX model. CRNDE was decreased and inhibited autophagy flux in chemoresistant GC cells. CRNDE directly bound to splicing protein SRSF6 to reduce its protein stability and thus regulate alternative splicing (AS) events. We determined that SRSF6 regulated the PICALM exon 14 skip splice variant and triggered a significant S-to-L isoform switch, which contributed to the expression of the long isoform of PICALM (encoding PICALML). Collectively, our findings reveal the key role of CRNDE in autophagy regulation, highlighting the significance of CRNDE as a potential prognostic marker and therapeutic target against chemoresistance in GC.
Mesh Terms:
Alternative Splicing, Autophagy, Cell Line, Tumor, Drug Resistance, Neoplasm, Fluorouracil, Humans, Monomeric Clathrin Assembly Proteins, Oxaliplatin, Phosphoproteins, Proteasome Endopeptidase Complex, Proteolysis, RNA, Long Noncoding, Serine-Arginine Splicing Factors, Stomach Neoplasms, Ubiquitination
Alternative Splicing, Autophagy, Cell Line, Tumor, Drug Resistance, Neoplasm, Fluorouracil, Humans, Monomeric Clathrin Assembly Proteins, Oxaliplatin, Phosphoproteins, Proteasome Endopeptidase Complex, Proteolysis, RNA, Long Noncoding, Serine-Arginine Splicing Factors, Stomach Neoplasms, Ubiquitination
Mol Cancer
Date: Jan. 04, 2021
PubMed ID: 33397371
View in: Pubmed Google Scholar
Download Curated Data For This Publication
243169
Switch View:
- Interactions 3